Arthritis & Rheumatism

PPI use ups risk of osteoporosis, osteopenia in femur

(HealthDay)—Proton pump inhibitor (PPI) use is associated with increased risk of developing osteoporosis and osteopenia in femur bones, according to a study published online May 31 in the International Journal of Rheumatic ...

Diseases, Conditions, Syndromes

New FRAX App launched by the International Osteoporosis Foundation

Osteoporosis management guidelines around the world now recommend that fracture risk assessment be part of any clinical evaluation for osteoporosis. As a result, rather than relying on bone mineral density values alone, physicians ...

Medications

Common osteoporosis drug slows formation of new bone

Although the drug zoledronic acid slows bone loss in osteoporosis patients, it also boosts levels of a biomarker that stops bone formation, according to a recent study accepted for publication in The Endocrine Society's Journal ...

Diseases, Conditions, Syndromes

Nano-enabled nasal spray for osteoporosis

The University of Nottingham spin-out company, Critical Pharmaceuticals, has announced a £545,000 collaboration with the University to develop a nano-enabled intranasal formulation of teriparatide for the treatment of ...

Diseases, Conditions, Syndromes

A crisis in the treatment of osteoporosis

The remarkable progress made over the past 30 years to reduce fractures and dramatically improve the quality of life for millions of osteoporosis patients is rapidly being reversed, say two bone health experts in a Journal ...

Diseases, Conditions, Syndromes

Consumer health: Preventing osteoporosis

Osteoporosis affects approximately 10 million people in the U.S., 80% of whom are women, according to the Office on Women's Health.

page 18 from 38